N Engl J Med 380:347357 Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, Charbonnel B, Frederich R, Gallo S, Cosentino F, Shih WJ, Gantz I, Terra SG, Cherney DZI, McGuire DK (2020) VERTIS CV Investigators
When the FDA removed tirzepatide in December 2024 and semaglutide in February 2025, they didnt just update a websitethey triggered a legal shutdown of the primary revenue stream for hundreds of facilities
Water Sci Technol 83:125
its once-weekly injection schedule greatly improves convenience and adherence compared to the more frequent dosing requirements of insulin
Younger adults are the most likely to have a fear of needles 18-24 year olds were the most likely age group to report a significant fear or phobia of needles, at 15.49%
So what are you burning